Discover the art of DIY jewelry as we guide you step-by-step through creating a beautiful matching bracelet and earrings set ...

Discover the art of wire wrapping and create unique jewelry pieces with this step by step tutorial. A creative way to design elegant handmade accessories. #DIY #WireJewelry #Handmade Paul Pelosi ...

In recent years, divorce rings have emerged as one of fine jewelry‘s most talked-about categories, transforming symbols of the past into pieces of personal reinvention. The trend gained mainstream ...

Amid the drama at the biotech, a new figure has stepped up right as the company needs a new long-term chief executive and chairman. Brian McNamee is CSL’s immovable object and unstoppable force. But ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

From blue-chip royalty to bin fire, the company’s staggering fall is a brutal reckoning for the Australian icon lost in its own complacency and hubris. Logic tells us worrying about round numbers in ...

In a 90-day review, CSL told the market it would take another $US5bn ($A6.9bn) non-cash impairment. The first $1.5bn of this was recognised during the first-half ...

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion, in another indication of the Australian company’s financial distress since its ill-fated 2022 ...

SYDNEY--Pharmaceutical company CSL on Monday downgraded its annual earnings guidance and signaled another $5 billion of pretax impairments, including for the Vifor business that it acquired for $11.7 ...

CSL trades at a discount despite owning a dominant, hard-to-replicate global plasma-derived therapies infrastructure. Transformation Program targets $500–$550M in annual pre-tax cost reductions by ...

What's next for the beaten-down ASX biotech stock? You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to ...

April 23 (Reuters) - Australian biotech giant CSL extended losses on Thursday, lingering near decade lows, after the U.S. military scrapped its flu vaccine mandate, dealing ‌another blow to the ...